FTC targets trans care providers for youth, investigating alleged deceptive practices

Matt Bishop
The FTC seeks to evaluate whether medical professionals violated the FTC Act by failing to disclose risks related to gender-affirming care.
Image credit: Andrew Harnik/Getty Images
13% left coverage46% right coverage

On Monday, the Federal Trade Commission (FTC) launched an inquiry to understand exposure to false claims about “gender-affirming care,” with public comments due by Sept. 26. The FTC seeks to evaluate whether medical professionals may have violated Sections 5 and 12 of the FTC Act by failing to disclose material risks related to gender-affirming care.

Kaiser Permanente and Children’s National Hospital announced they will no longer provide gender transition-related medical interventions due to federal scrutiny of transgender care.

QR code for SAN app download

Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.

Point phone camera here

Children’s National Hospital also said it will discontinue prescribing gender-affirming medications, effective Aug. 30.

Discover reporting you’re not seeing from biased, mainstream media outlets.

Using our real-time Media Miss™ tool powered by Ground News, we spotlight stories that right-leaning and left-leaning news outlets aren’t covering to bring you a complete picture of the news.

Learn more about how Media Miss™ works.

Media Landscape

Click on bars to see headlines

23 total sources

Other (sources without bias rating):

Powered by Ground News™

Powered by Ground News™